Article,

Irinotecan and vandetanib create synergies for treatment of pancreatic cancer patients with concomitant TP53 and KRAS mutations.

, , , and .
Briefings Bioinform., (2021)

Meta data

Tags

Users

  • @dblp

Comments and Reviews